Investigating 5-Hydroxymethylcytosine (5hmC): The State of the Art

  • Colm E. Nestor
  • James P. Reddington
  • Mikael Benson
  • Richard R. Meehan
Part of the Methods in Molecular Biology book series (MIMB, volume 1094)

Abstract

The discovery of 5-hydroxymethylcytosine (5hmC) as an abundant base in mammalian genomes has excited the field of epigenetics, and stimulated an intense period of research activity aimed at decoding its biological significance. However, initial research efforts were hampered by a lack of assays capable of specifically detecting 5hmC. Consequently, the last 3 years have seen the development of a plethora of new techniques designed to detect both global levels and locus-specific profiles of 5hmC in mammalian genomes. This research effort has culminated in the recent publication of two complementary techniques for quantitative, base-resolution mapping of 5hmC in mammalian genomes, the first true mammalian hydroxymethylomes. Here, we review the techniques currently available to researchers studying 5hmC, discuss their advantages and disadvantages, and explore the technical hurdles which remain to be overcome.

Key words

DNA methylation reprogramming 5mC 5hmC 5fC 5caC Gene regulation Epigenetics 

Notes

Acknowledgements

We thank members of the Meehan lab for advice on the development and application of 5hmC protocols. Work in RM’s lab is supported by the Medical Research Council, by the BBSRC, and by the Innovative Medicines Initiative Joint Undertaking (IMI JU) under grant agreement number 115001 (MARCAR project). URL: http://www.imi-marcar.eu/.

References

  1. 1.
    Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16:6–21PubMedCrossRefGoogle Scholar
  2. 2.
    Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915–926PubMedCrossRefGoogle Scholar
  3. 3.
    Okano M, Bell DW, Haber DA et al (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247–257PubMedCrossRefGoogle Scholar
  4. 4.
    Kriaucionis S, Heintz N (2009) The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324:929–930PubMedCrossRefGoogle Scholar
  5. 5.
    Tahiliani M, Koh KP, Shen Y et al (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930–935PubMedCrossRefGoogle Scholar
  6. 6.
    Ficz G, Branco MR, Seisenberger S et al (2011) Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473:398–402PubMedCrossRefGoogle Scholar
  7. 7.
    Wu H, D’Alessio AC, Ito S et al (2011) Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev 25:679–684PubMedCrossRefGoogle Scholar
  8. 8.
    Nestor CE, Ottaviano R, Reddington J et al (2011) Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res 22:467–477PubMedCrossRefGoogle Scholar
  9. 9.
    Stroud H, Feng S, Morey Kinney S et al (2011) 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol 12:R54PubMedCrossRefGoogle Scholar
  10. 10.
    Jin SG, Kadam S, Pfeifer GP (2010) Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res 38:e125PubMedCrossRefGoogle Scholar
  11. 11.
    Valinluck V, Tsai HH, Rogstad DK et al (2004) Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 32:4100–4108PubMedCrossRefGoogle Scholar
  12. 12.
    Fraga MF, Ballestar E, Montoya G et al (2003) The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res 31:1765–1774PubMedCrossRefGoogle Scholar
  13. 13.
    Hendrich B, Bird A (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18:6538–6547PubMedGoogle Scholar
  14. 14.
    Saito M, Ishikawa F (2002) The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. J Biol Chem 277:35434–35439PubMedCrossRefGoogle Scholar
  15. 15.
    Yildirim O, Li R, Hung JH et al (2011) Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells. Cell 147:1498–1510PubMedCrossRefGoogle Scholar
  16. 16.
    Hajkova P, Erhardt S, Lane N et al (2002) Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 117:15–23PubMedCrossRefGoogle Scholar
  17. 17.
    Mayer W, Niveleau A, Walter J et al (2000) Demethylation of the zygotic paternal genome. Nature 403:501–502PubMedCrossRefGoogle Scholar
  18. 18.
    Oswald J, Engemann S, Lane N et al (2000) Active demethylation of the paternal genome in the mouse zygote. Curr Biol 10:475–478PubMedCrossRefGoogle Scholar
  19. 19.
    Saitou M, Kagiwada S, Kurimoto K (2012) Epigenetic reprogramming in mouse pre-implantation development and primordial germ cells. Development 139:15–31PubMedCrossRefGoogle Scholar
  20. 20.
    Bhutani N, Brady JJ, Damian M et al (2010) Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463:1042–1047PubMedCrossRefGoogle Scholar
  21. 21.
    Guo JU, Su Y, Zhong C et al (2011) Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145:423–434PubMedCrossRefGoogle Scholar
  22. 22.
    Kangaspeska S, Stride B, Metivier R et al (2008) Transient cyclical methylation of promoter DNA. Nature 452:112–115PubMedCrossRefGoogle Scholar
  23. 23.
    Martinowich K, Hattori D, Wu H et al (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302:890–893PubMedCrossRefGoogle Scholar
  24. 24.
    Metivier R, Gallais R, Tiffoche C et al (2008) Cyclical DNA methylation of a transcriptionally active promoter. Nature 452:45–50PubMedCrossRefGoogle Scholar
  25. 25.
    Bruniquel D, Schwartz RH (2003) Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 4:235–240PubMedCrossRefGoogle Scholar
  26. 26.
    Ma DK, Jang MH, Guo JU et al (2009) Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 323:1074–1077PubMedCrossRefGoogle Scholar
  27. 27.
    Ito S, Shen L, Dai Q et al (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333:1300–1303PubMedCrossRefGoogle Scholar
  28. 28.
    Wu SC, Zhang Y (2010) Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 11:607–620PubMedCrossRefGoogle Scholar
  29. 29.
    Iqbal K, Jin SG, Pfeifer GP et al (2011) Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc Natl Acad Sci U S A 108:3642–3647PubMedCrossRefGoogle Scholar
  30. 30.
    Wossidlo M, Nakamura T, Lepikhov K et al (2011) 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat Commun 2:241PubMedCrossRefGoogle Scholar
  31. 31.
    Inoue A, Zhang Y (2011) Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science 334:194PubMedCrossRefGoogle Scholar
  32. 32.
    Valinluck V, Sowers LC (2007) Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 67:946–950PubMedCrossRefGoogle Scholar
  33. 33.
    Nabel CS, Jia H, Ye Y et al (2012) AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation. Nat Chem Biol 8:751–758PubMedCrossRefGoogle Scholar
  34. 34.
    Lister R, Pelizzola M, Dowen RH et al (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462:315–322PubMedCrossRefGoogle Scholar
  35. 35.
    Huang Y, Pastor WA, Shen Y et al (2010) The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 5:e8888PubMedCrossRefGoogle Scholar
  36. 36.
    Nestor C, Ruzov A, Meehan R et al (2010) Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 48:317–319PubMedCrossRefGoogle Scholar
  37. 37.
    Hayatsu H, Shiragami M (1979) Reaction of bisulfite with the 5-hydroxymethyl group in pyrimidines and in phage DNAs. Biochemistry 18:632–637PubMedCrossRefGoogle Scholar
  38. 38.
    Branco MR, Ficz G, Reik W (2012) Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet 13:7–13Google Scholar
  39. 39.
    Tan L, Shi YG (2012) Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 139:1895–1902PubMedCrossRefGoogle Scholar
  40. 40.
    Williams K, Christensen J, Helin K (2012) DNA methylation: TET proteins-guardians of CpG islands? EMBO Rep 13:28–35CrossRefGoogle Scholar
  41. 41.
    Globisch D, Munzel M, Muller M et al (2010) Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 5:e15367PubMedCrossRefGoogle Scholar
  42. 42.
    Nestor CE, Ottaviano R, Reddington J et al (2012) Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res 22:467–477PubMedCrossRefGoogle Scholar
  43. 43.
    Szwagierczak A, Bultmann S, Schmidt CS et al (2010) Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res 38:e181PubMedCrossRefGoogle Scholar
  44. 44.
    Weisenberger DJ, Campan M, Long TI et al (2005) Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 33:6823–6836PubMedCrossRefGoogle Scholar
  45. 45.
    Ehrlich M, Gama-Sosa MA, Huang LH et al (1982) Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res 10:2709–2721PubMedCrossRefGoogle Scholar
  46. 46.
    Ruzov A, Tsenkina Y, Serio A et al (2011) Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development. Cell Res 21:1332–1342PubMedCrossRefGoogle Scholar
  47. 47.
    Thomson JP, Lempiäinen H, Hackett J et al (2012) Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome. Genome Biol 13(10):R93PubMedCrossRefGoogle Scholar
  48. 48.
    Haffner MC, Chaux A, Meeker AK et al (2011) Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2:627–637PubMedGoogle Scholar
  49. 49.
    Szulwach KE, Li X, Li Y et al (2011) Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet 7:e1002154PubMedCrossRefGoogle Scholar
  50. 50.
    Terragni J, Bitinaite J, Zheng Y et al (2012) Biochemical characterization of recombinant beta-glucosyltransferase and analysis of global 5-hydroxymethylcytosine in unique genomes. Biochemistry 51:1009–1019PubMedCrossRefGoogle Scholar
  51. 51.
    Williams K, Christensen J, Pedersen MT et al (2011) TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473:343–348PubMedCrossRefGoogle Scholar
  52. 52.
    Pastor WA, Pape UJ, Huang Y et al (2011) Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473:394–397PubMedCrossRefGoogle Scholar
  53. 53.
    Robertson AB, Dahl JA, Vagbo CB et al (2011) A novel method for the efficient and selective identification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res 39:e55PubMedCrossRefGoogle Scholar
  54. 54.
    Song CX, Szulwach KE, Fu Y et al (2011) Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol 29:68–72PubMedCrossRefGoogle Scholar
  55. 55.
    Robertson AB, Dahl JA, Ougland R et al (2012) Pull-down of 5-hydroxymethylcytosine DNA using JBP1-coated magnetic beads. Nat Protoc 7:340–350PubMedCrossRefGoogle Scholar
  56. 56.
    Ko M, Huang Y, Jankowska AM et al (2010) Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468:839–843PubMedCrossRefGoogle Scholar
  57. 57.
    Song CX, Clark TA, Lu XY et al (2012) Sensitive and specific single-molecule sequencing of 5-hydroxymethylcytosine. Nat Methods 9:75–77CrossRefGoogle Scholar
  58. 58.
    Salbert G, Weber M (2012) Tracking genomic hydroxymethylation by the base. Nat Methods 9:45–46CrossRefGoogle Scholar
  59. 59.
    Eid J, Fehr A, Gray J et al (2009) Real-time DNA sequencing from single polymerase molecules. Science 323:133–138PubMedCrossRefGoogle Scholar
  60. 60.
    Flusberg BA, Webster DR, Lee JH et al (2010) Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat Methods 7:461–465PubMedCrossRefGoogle Scholar
  61. 61.
    Kinney SM, Chin HG, Vaisvila R et al (2011) Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes. J Biol Chem 286:24685–24693PubMedCrossRefGoogle Scholar
  62. 62.
    Booth MJ, Branco MR, Ficz G et al (2012) Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 336:934–937PubMedCrossRefGoogle Scholar
  63. 63.
    Ball MP, Li JB, Gao Y et al (2009) Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 27:361–368PubMedCrossRefGoogle Scholar
  64. 64.
    Colaneri A, Staffa N, Fargo DC et al (2011) Expanded methyl-sensitive cut counting reveals hypomethylation as an epigenetic state that highlights functional sequences of the genome. Proc Natl Acad Sci U S A 108:9715–9720PubMedCrossRefGoogle Scholar
  65. 65.
    Khulan B, Thompson RF, Ye K et al (2006) Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res 16:1046–1055PubMedCrossRefGoogle Scholar
  66. 66.
    Khare T, Pai S, Koncevicius K et al (2012) 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary. Nat Struct Mol Biol 19:1037–1043PubMedCrossRefGoogle Scholar
  67. 67.
    Yu M, Hon GC, Szulwach KE et al (2012) Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 149:1368–1380PubMedCrossRefGoogle Scholar
  68. 68.
    Down TA, Rakyan VK, Turner DJ et al (2008) A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol 26:779–785PubMedCrossRefGoogle Scholar
  69. 69.
    Pelizzola M, Koga Y, Urban AE et al (2008) MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment. Genome Res 18:1652–1659PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, New York 2014

Authors and Affiliations

  • Colm E. Nestor
    • 1
    • 2
  • James P. Reddington
    • 1
  • Mikael Benson
    • 2
  • Richard R. Meehan
    • 1
  1. 1.MRC Human Genetics Unit, IGMMUniversity of Edinburgh, Western General HospitalEdinburghUK
  2. 2.The Centre for Individualised Medication, Linkoping University HospitalLinkoping UniversityLinkopingSweden

Personalised recommendations